Circulating Fetuin-A levels are higher in human subjects with obesity, type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD) (52). Here, AHSG is linked to metabolic dysfunction-associated steatotic liver disease.